Key market opportunities in the microbiology culture market include the rising demand for rapid diagnostics, adoption of ...

The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by ...

If you are wondering whether Merck's current share price reflects its true worth, this article walks through what the numbers ...

Sun Pharmaceutical, India’s largest drugmaker by market capitalisation and revenue, is evaluating the acquisition of US-based ...

Sun Pharma is weighing the acquisition of US-based Organon in a deal valued at about $10 billion, a move that would ...

India's largest drugmaker, Sun Pharma, is considering a major acquisition. The company is evaluating the purchase of US-based ...

The lender earned $4.88 per share, easily beating Wall Street's estimate of $4.20. Revenue of $6.07 billion came in higher ...

READ ALSO 7 Stocks on Jim Cramer’s Radar Recently and Jim Cramer Recently Looked At These 16 Stocks ...

Oil slips on potential de-escalation of tensions between U.S. and Iran ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite.